ストックスクリーナーアプリを入手
233.01
0.55%
-1.29
Quest Diagnostics Inc (DGX) 最新ニュース
Insider at DGX (NYSE: DGX) plans sale of 1,600 common shares - Stock Titan
JPMorgan Adjusts Price Target on Quest Diagnostics to $250 From $220, Maintains Neutral Rating - marketscreener.com
DGX|Quest Diagnostics Inc|Price:231.750|Chg%:+3.890 - TradingKey
Quest Diagnostics Inc (DGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 Quest Diagnostics orporated For: 28 July By Investing.com - Investing.com South Africa
Quest Diagnostics Inc (DGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Diagnostics (NYSE: DGX) SVP adds shares via dividend reinvestment plan - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP acquires 34.0000 shares via dividend reinvestment - Stock Titan
Rothschild & Co Redburn Adjusts Quest Diagnostics Price Target to $251 From $233, Maintains Buy Rating - Moomoo
Quest Diagnostics (DGX) Leads S&P 500 Healthcare Gainers with 8. - GuruFocus
Quest Diagnostics Incorporated (DGX) Stock forecasts - Yahoo Finance Singapore
Quest Diagnostics stock trades steady as earnings and diagnostics demand shape investor focus - Ad-hoc-news.de
Quest Diagnostics Inc (DGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quest Diagnostics Inc (DGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail
Quest Diagnostics Inc (DGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Quest Diagnostics Is Maintained at Outperform by Mizuho - Moomoo
Quest Diagnostics Inc (DGX) Cash Flow - TradingKey
DGX|Quest Diagnostics Inc|Price:227.860|Chg%:-0.050 - TradingKey
Quest Diagnostics Inc (DGX) Institutional Confidence - TradingKey
Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Quest Diagnostics Inc (DGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Q2 2026 Quest Diagnostics Inc Earnings Call Transcript - GuruFocus
Quest Diagnostics Q2 2026 Earnings: Net Income, Revenues, and Financial Highlights from SEC 10-Q Filing - Minichart
QUEST DIAGNOSTICS INC : TRUIST SECURITIES RAISES TARGET PRICE TO $250 FROM $225 - Bitget
UBS Adjusts Price Target on Quest Diagnostics to $232 From $220, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Quest Diagnostics Price Target to $255 From $236, Maintains Neutral Rating - marketscreener.com
Barclays Raises Quest Diagnostics Price Target to $250 From $230, Maintains Overweight Rating - marketscreener.com
Mizuho Securities Adjusts Quest Diagnostics Price Target to $260 From $235, Maintains Outperform Rating - marketscreener.com
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $241.73, Implies 6% Upside - TradingView
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Deutsche Bank Adjusts Quest Diagnostics Price Target to $232 From $205, Maintains Hold Rating - marketscreener.com
Truist Raises Price Target on Quest Diagnostics to $250 From $225, Keeps Hold Rating - marketscreener.com
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $240.93, Implies 6% Upside - TradingView
Quest Diagnostics Upgrades EPS Outlook For 2026 After Outperforming Q2 Results (NYSE:DGX) - Seeking Alpha
Morgan Stanley Adjusts PT on Quest Diagnostics to $260 From $226, Maintains Overweight Rating - marketscreener.com
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $239.27, Implies 5% Upside - TradingView
Quest Diagnostics stock trades steady as investors weigh recent earnings and diagnostics demand - Ad-hoc-news.de
Quest Diagnostics Inc (DGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Trending Industry Today: Quest Diagnostics Leads Gains In CRO Stocks - Moomoo
Quest Diagnostics Inc (DGX) Shares Surge 8.6% -- What GF Score o - GuruFocus
Quest Diagnostics Incorporated Q2 2026 Earnings Call Summary - Yahoo Finance
Quest Continues to Build on Its Hospital Lab Collaborations - Morningstar
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $229.6, Implies 9% Upside - TradingView
Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: St - GuruFocus
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics 2026: Revenue $3.04B, EPS $2.84— 10-Q Summary - TradingView
Quest Diagnostics (NYSE: DGX) lifts Q2 EPS to $2.84 on 10% revenue growth - Stock Titan
Quest Diagnostics Q2 Earnings Call Highlights - TradingView
Quest Diagnostics Stock Gains As Oncology Moves Impress Wall Street - StocksToTrade
Quest Diagnostics Stock Hits 52-Week HighHere's WhyQuest Diagnostics (NYSE:DGX) - Benzinga
Evercore ISI Cuts Quest Diagnostics Price Target to $240 From $225 - marketscreener.com
Quest Diagnostics raises annual forecast on testing demand - Reuters
Is Quest Diagnostics Inc (DGX) Overvalued After Q2 Earnings Beat - GuruFocus
Quest Diagnostics Q2 2026 Results: Revenue Surges 10%, EPS Up 19%, Full-Year Guidance Raised - Minichart
Quest Diagnostics Announces Q2 2026 Financial Results and Operational Highlights - Kalkine Media
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday - Benzinga
Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. - marketscreener.com
Quest Diagnostics stock hits all-time high at 227.31 USD By Investing.com - Investing.com Canada
Transcript: Quest Diagnostics Q2 2026 Earnings Conference Call - Benzinga
DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised - TradingView
Quest Diagnostics Exec Says Fewer Physician R - Moomoo
Quest Diagnostics Raises Earnings Guidance for the Full Year 2026 - marketscreener.com
Quest’s (NYSE:DGX) Q2 CY2026: Beats On Revenue, Stock Soars - Yahoo Finance
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Quest Diagnostics raises full-year guidance after Q2 revenue rises 10.2% - scanx.trade
2.63%
0.83%
大文字化:
|
ボリューム (24 時間):